Case Study: Protocol PSK00010
A Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants, Toddlers, Children, and Adolescents
Study Objectives and Results
Objectives
- Global Enrollment Goal: 1252 Participants
- QCR Enrollment Goal: 25 Participants
- Enrollment Window: 3 Months
- Target Population: Ages 7 months to 17 years
- Disease Characteristics: Participants who are healthy with a specific vaccine status
Quality Clinical Research achieved its enrollment goal 6 weeks before the enrollment window closed. Given this success, QCR was authorized to enroll beyond its initial target. This study had competitive enrollment and QCR outpaced average site enrollment. QCR’s contribution underscored its ability to exceed ambitious enrollment goals, reflecting its operational excellence.
Quality Clinical Research was mentioned consistently in sponsor newsletters as a top site for our 96% diary compliance.
Result 01
34 Patients Enrolled
Result 02
2.7% of Trial Population
Result 03
Outpaced Average Site Enrollment
